 JUPITER, Fla., May 20, 2022 GLOBE NEWSWIRE -- Dyadic International, Inc. Dyadic, or the Company NASDAQ: DYAI a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company will participate in the 2022 H.C. Wainwright Global Investment Conference at the Fontainebleau Miami Beach Hotel in Miami Florida. The hybrid conference will take place May 23rd - 26th, 2022. Dyadic s President and CEO, Mark Emalfarb will be presenting on Wednesday, May 25, 2022, at 12:30 PM ET. 